# Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration

> **NCT00000563** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Lung Diseases
- Respiratory Distress Syndrome

## Interventions

- **DRUG:** dexamethasone

## Key facts

- **NCT ID:** NCT00000563
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1976-06
- **Primary completion:** —
- **Final completion:** 1983-08
- **Target enrollment:** — (—)
- **Last updated:** 2012-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000563, "Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00000563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*